Clinical significance of Ki-67 labeling index in pituitary macroadenoma

被引:51
作者
Paek, KI [1 ]
Kim, SH [1 ]
Song, SH [1 ]
Choi, SW [1 ]
Koh, HS [1 ]
Youm, JY [1 ]
Kim, Y [1 ]
机构
[1] Chungnam Natl Univ, Coll Med, Dept Neurosurg, Taejon, South Korea
关键词
pituitary neoplasms; Ki-67; antigen; recurrence;
D O I
10.3346/jkms.2005.20.3.489
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of our study was to investigate the correlation of the proliferative activity of pituitary neoplasms with clinical characteristics and recurrences. Tumor specimens were obtained from 44 consecutive patients with pituitary macroadenomas who underwent surgery between July 1998 and August 2003. Specimens were immediately fixed in 10% buffered formalin and then embedded in paraffin. The Ki-67 antigen was assessed by immumohistochemical analysis using the monoclonal antibody. We investigated the correlation of the Ki-67 labeling index with the following clinical and radiological characteristics: sex, age, presence or absence visual field defect, tumor classification, maximal tumor diameter, Hardy's classification, type of tumor, invasiveness, and recurrence. Our study suggests that the clinical characteristics such as visual field defect and recurrence are correlated with the high Ki-67 labeling index. No statistical differences were observed in the Ki-67 labeling index in relation to the following characteristics: sex, age, tumor classification, maximal tumor diameter, Hardy's classification, type of tumor, and invasiveness into the sphenoid sinus or cavernous sinus.
引用
收藏
页码:489 / 494
页数:6
相关论文
共 33 条
[1]   PITUITARY-ADENOMA PROLIFERATIVE INDEXES AND RISK OF RECURRENCE [J].
CARBONI, P ;
DETTA, A ;
HITCHCOCK, ER ;
POSTANS, R .
BRITISH JOURNAL OF NEUROSURGERY, 1992, 6 (01) :33-40
[2]   MONOCLONAL-ANTIBODIES AGAINST RECOMBINANT PARTS OF THE KI-67 ANTIGEN (MIB-1 AND MIB-3) DETECT PROLIFERATING CELLS IN MICROWAVE-PROCESSED FORMALIN-FIXED PARAFFIN SECTIONS [J].
CATTORETTI, G ;
BECKER, MHG ;
KEY, G ;
DUCHROW, M ;
SCHLUTER, C ;
GALLE, J ;
GERDES, J .
JOURNAL OF PATHOLOGY, 1992, 168 (04) :357-363
[3]  
COMTOIS R, 1991, CANCER, V68, P860, DOI 10.1002/1097-0142(19910815)68:4<860::AID-CNCR2820680431>3.0.CO
[4]  
2-4
[5]   Sex-related difference in the growth of prolactinomas: A clinical and proliferation marker study [J].
Delgrange, E ;
Trouillas, J ;
Maiter, D ;
Donckier, J ;
Tourniaire, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (07) :2102-2107
[6]   The correlation of Ki-67 staining indices with tumour doubling times in regrowing non-functioning pituitary adenomas [J].
Ekramullah, SM ;
Saitoh, Y ;
Arita, N ;
Ohnishi, T ;
Hayakawa, T .
ACTA NEUROCHIRURGICA, 1996, 138 (12) :1449-1455
[7]  
GANDOUREDWARDS R, 1995, MODERN PATHOL, V8, P160
[8]  
Gerdes J, 1990, Semin Cancer Biol, V1, P199
[9]  
Hardy J, 1973, INT C SERIES, V303, P179
[10]  
HUS D, 1993, J NEUROSURG, V78, P753